References
- Pauletti GM, Gangwar S, Siahaan TJ, Aube J. (1997). Improvement of oral peptide bioavailability: Peptidomimetics and prodrug strategies. Adv Drug Deliv Rev, 27:235–256.
- Anderson KE, Stevenson BR, Rogers JA. (1999). Folic acid-PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents. J Control Release, 60:189–198.
- Chiang CM, Weiner N. (1987). Gastrointestinal uptake of liposomes II. In vivo studies. Int J Pharm, 40:143–150.
- Guo J, Ping Q, Jiang G, Huang L, Tong Y. (2003). Chitosan-coated liposomes: Characterization and interaction with leuprolide. Int J Pharm, 260:167–173.
- Iwanaga K, Ono S, Narioka K, Morimoto K, Kakemi M, Yamashita S, Nango M, Oku N. (1997). Oral delivery of insulin by using surface coating liposomes: Improvement of stability of insulin in GI tract. Int J Pharm, 157:73–80.
- Sarmento B, Ferreira DC, Jorgensen L, van de Weert M. (2007). Probing insulin’s secondary structure after entrapment into alginate/chitosan nanoparticles. Eur J Pharm Biopharm, 65:10–17.
- Song KH, Chung SJ, Shim CK. (2002). Preparation and evaluation of proliposomes containing salmon calcitonin. J Control Release, 84:27–37.
- Ueno M. (1998). Liposomal heparin by the oral route. In: Gregoriadis G, (ed). Liposomes as Drug Carriers. New York: John Wiley & Son, pp. 609–619.
- Witoonsaridsilp W, Panyarachun B, Sarisuta N, Müller-Goymann CC. (2010). Influence of microenvironment and liposomal formulation on secondary structure and bilayer interaction of lysozyme. Colloids Surf B Biointerfaces, 75:501–509.
- Yamabe K, Kato Y, Onishi H, Machida Y. (2003). Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release, 89:429–436.
- van Winden ECA, Crommelin DJA. (1997). Long term stability of freeze-dried, lyoprotected doxorubicin liposomes. Eur J Pharm Biopharm, 43:295–307.
- Barenholz Y, Crommelin DJA. (1994). Liposomes as pharmaceutical dosage forms. In: Boylan JC, (ed). Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, pp. 1–39.
- Payne NI, Timmins P, Ambrose CV, Ward MD, Ridgway F. (1986). Proliposomes: A novel solution to an old problem. J Pharm Sci, 75:325–329.
- Hwang BY, Jung BH, Chung SJ, Lee MH, Shim, CK. (1997). In vitro skin permeation of nicotine from proliposomes. J Control Release, 49:177–184.
- Ning MY, Guo YZ, Pan HZ, Yu HM, Gu ZW. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull, 53:620–624.
- Yang ZJ, Hino T, Kawashima Y. (1993). Studies on the size of rehydrated new liposome from Scutellaria proliposomes. J Chin Pharm Univ, 24:161–164.
- Chu MQ, Gu HC. (2002). The study on the preparation of tanshonones propoliposomes by the spray drying method. Chin Pharm J, 37:32–35.
- Wei NN, Lu BI. (2003). Preparation, morphology and in vitro release of chitosan coated liposomes of fluorouracil for colon targeting. Acta Pharm Sinica, 38:53–56.
- Hill M, Lapcík O, Hampl R. (1997). Evaluation and separation of steroid-bovine serum albumin conjugates by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl, 691:187–191.
- ICH Q2B Guideline, (1996). Guideline on validation of analytical procedures: Methodology.
- Dong A, Huang P, Caughey WS. (1990). Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry, 29:3303–3308.
- Banerjee S, Li D. (1991). Interpreting multicomponent infrared spectra by derivative minimization. Appl Spectrosc, 45:1047–1049.
- Fabian H, Schultz C, Naumann D, Landt O, Hahn U, Saenger W. (1993). Secondary structure and temperature-induced unfolding and refolding of ribonuclease T1 in aqueous solution. A Fourier transform infrared spectroscopic study. J Mol Biol, 232:967–981.
- Gorga JC, Dong A, Manning MC, Woody RW, Caughey WS, Strominger JL. (1989). Histocompatibility complex antigens by Fourier transform infrared and circular dichroism: Comparison of the secondary structures of human class I and class II major spectroscopy. Proc Natl Acad Sci USA, 86, 2321–2325.
- Griebenow K, Klibanov AM. (1996). On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. J Am Chem Soc, 118:11695–11700.
- Fang JY, Yu SY, Wu PC, Huang YB, Tsai YH. (2001). In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm, 215:91–99.
- Peters TJr. (1985). Serum albumin. Adv Protein Chem, 37:161–245.
- Kragh-Hansen U. (1981). Molecular aspects of ligand binding to serum albumin. Pharmacol Rev, 33:17–53.
- McLachlan AD, Walker JE. (1977). Evolution of serum albumin. J Mol Biol, 112:543–558.
- Law SL, Lo WY, Lin M. (1994). Increase of liposome stability by incorporation of bovine serum albumin. Drug Dev Ind Pharm, 20:1411–1423.
- Ermak TH, Giannasca PJ. (1998). Microparticle targeting to M cells. Adv Drug Deliv Rev, 34:261–283.
- Miyazawa T, Shimanouchi T, Mizushima SI. (1956). Characteristic infrared bands of mono-substituted amides. J Chem Phys, 24:408–418.
- Susi H. (1972). Infrared spectroscopy–conformation. Meth Enzymol, 26 PtC:455–472.
- Susi H, Timasheff SN, Stevens L. (1967). Infrared spectra and protein conformations in aqueous solutions. I. The amide I band in H2O and D2O solutions. J Biol Chem, 242:5460–5466.
- Timascheff F, Susi H, Stevens L. (1967). Infrared spectra and protein. J Biol Chem, 242:5467–5473.
- Wang FYZ, Zhou Y, Wang S, Zhang L, Wu J. (2006). Influence of metal ions on phosphatidylcholine-bovine serum albumin model membrane, an FTIR study. J Mol Structure, 794:1–11.
- Makarov MI, Haumaier L, Zech W. (2002). Nature of soil organic phosphorus: An assessment of peak assignments in the diester region of 31P NMR spectra. Soil Biol Biochem, 24:1467–1477.